C1QTNF9 and coronary atherosclerosis: The therapeutic effect of CTRP9 in coronary atherosclerosis is based on the promotion of high‐density lipoprotein cholesterol (HDL‐C) synthesis in patients suffering from diet‐induced obesity.23